What is the latest news on EVOK?

Quantisnow has not tracked any new filings, ratings or press releases for EVOK in the last 30 days. The most recent wire item was published on December 30, 2025.

Where does EVOK stock trade?

Evoke Pharma Inc. (EVOK) is listed on NASDAQ.

What sector and industry is EVOK in?

Evoke Pharma Inc. operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry.

When did Evoke Pharma Inc. go public?

Evoke Pharma Inc. (EVOK) completed its IPO in 2013.

What companies are similar to EVOK?

Notable peers in the same industry include NVO (Novo Nordisk A/S), AZN (AstraZeneca PLC), JNJ (Johnson & Johnson), ABT (Abbott Laboratories), MRK (Merck & Company Inc.). Compare EVOK side-by-side with any of them on Quantisnow.

How can I track EVOK on Quantisnow?

Quantisnow aggregates Evoke Pharma Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow EVOK to receive live email and push alerts on every new disclosure.

EVOK

NASDAQ

Evoke Pharma Inc.

SectorHealth Care IndustryBiotechnology: Pharmaceutical PreparationsIPO2013

Follow + get alerts

Website

Evoke Pharma Inc. (EVOK) is a Biotechnology: Pharmaceutical Preparations company listed on NASDAQ. There were no new wire items for EVOK in the last 30 days. The most recent was published Dec 30, 2025.

Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It is developing Gimoti, a metoclopramide nasal spray that has completed Phase III clinical trials to treat symptoms associated with acute and recurrent diabetic gastroparesis in females. The company markets its products to gastroenterologists, internal medicine specialists, primary care physicians, and select health care providers. Evoke Pharma, Inc. was incorporated in 2007 and is headquartered in Solana Beach, California.

Latest news

25 items

EVOK FAQ

7 questions

What does Evoke Pharma Inc. do?
Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It is developing Gimoti, a metoclopramide nasal spray that has completed Phase III clinical trials to treat symptoms associated with acute and recurrent diabetic gastroparesis in females. The company markets its products to gastroenterologists, internal medicine specialists, primary care physicians, and select health care providers. Evoke Pharma, Inc. was incorporated in 2007 and is headquartered in Solana...
What is the latest news on EVOK?
Quantisnow has not tracked any new filings, ratings or press releases for EVOK in the last 30 days. The most recent wire item was published on December 30, 2025.
Where does EVOK stock trade?
Evoke Pharma Inc. (EVOK) is listed on NASDAQ.
What sector and industry is EVOK in?
Evoke Pharma Inc. operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry.
When did Evoke Pharma Inc. go public?
Evoke Pharma Inc. (EVOK) completed its IPO in 2013.
What companies are similar to EVOK?
Notable peers in the same industry include NVO (Novo Nordisk A/S), AZN (AstraZeneca PLC), JNJ (Johnson & Johnson), ABT (Abbott Laboratories), MRK (Merck & Company Inc.). Compare EVOK side-by-side with any of them on Quantisnow.
How can I track EVOK on Quantisnow?
Quantisnow aggregates Evoke Pharma Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow EVOK to receive live email and push alerts on every new disclosure.